The problem we solve: Covid is a major pandemic and effective treatment is required
About our solution: 2 of the three molecules are already proven in invitro test. We have added one more off patent drug in the formulation. The topical application is easy and effective. The plant based alkaloid inhibits viral replication along with being anti-inflammatory and off patent drugs acts on various pathways.Progress to date:
Formulation ready to be tested invitro at CCMB Hyderabad for Covid.
Creator: Subhramani Naidu
Bio: A business researcher with top tier investment banking having expertise across sectors and geographies.
Title: Project Head
TAM - 169,736,766 recovered patient &
Unestimated preventive market for mild and moderate cases
Projected 3 Year Growth
Estimated revenue in 3 years $15 million
Sustainable revenue model by exclusive sales of product globally
Vaccine makers and any other new treatments
Center for molecular Biology agreed to test our formulation invitro for Covid based on the molecules profile.
Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.
There are not supporters yet.
No updates found .
Help us find best new ideas to fund by telling us what you think. Your feedback goes straight to the team behind this project in private, so tell them what you really think.